LONDON, England, Feb. 27 -- Gut, a peer reviewed journal in gastroenterology and hepatology from the British Society of Gastroenterology and BMJ, issued research articles in its March 2024 edition (Vol. 73, Issue 3):

Commentaries:

* More than shots in the dark: improving patient stratification to move closer to personalised therapies in intrahepatic cholangiocarcinoma

* Ebastine for the treatment of irritable bowel syndrome: old drug, new tricks?